<?xml version="1.0" encoding="UTF-8" ?><xml><records><record><database name="SpiderCite demo.enl" path="C:\Users\jclark\OneDrive - Bond University\Training\2023\Workshop 1 SRA overview training\SRA overview demo files\09 SpiderCite\SpiderCite demo.enl">SpiderCite demo.enl</database><source-app name="EndNote" version="20.4">EndNote</source-app><rec-number>2</rec-number><foreign-keys><key app="EN" db-id="e2trw50reds29qedswuva59vp5dpt5f5a9er">2</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Antoniou, C.</style></author><author><style face="normal" font="default" size="100%">Dessinioti, C.</style></author><author><style face="normal" font="default" size="100%">Sotiriadis, D.</style></author><author><style face="normal" font="default" size="100%">Kalokasidis, K.</style></author><author><style face="normal" font="default" size="100%">Kontochristopoulos, G.</style></author><author><style face="normal" font="default" size="100%">Petridis, A.</style></author><author><style face="normal" font="default" size="100%">Rigopoulos, D.</style></author><author><style face="normal" font="default" size="100%">Vezina, D.</style></author><author><style face="normal" font="default" size="100%">Nikolis, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">1st Department of Dermatology, University of Athens, Andreas Sygros Hospital, Athens, Greece. anikolis@vicpark.com.&#xD;1st Department of Dermatology, University of Athens, Andreas Sygros Hospital, Athens, Greece.&#xD;Department of Dermatology, Aristotle University of Thessaloniki Medical School, Papageorgiou General Hospital, Thessaloniki, Greece.&#xD;2nd Department of Dermatology, Andreas Sygros Hospital, Athens, Greece.&#xD;3rd Department of Dermatology, Andreas Sygros Hospital, Athens, Greece.&#xD;University of Athens, Attikon University General Hospital of Athens, Athens, Greece.&#xD;KLOX Technologies Inc., Laval, Canada.&#xD;Division of Plastic Surgery, University of Montreal, Montreal, Canada.&#xD;Victoria Park Research Centre, Plastic Surgery Section, Montreal, Canada.</style></auth-address><titles><title><style face="normal" font="default" size="100%">A multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Dermatol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Dermatol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1321-1328</style></pages><volume><style face="normal" font="default" size="100%">55</style></volume><number><style face="normal" font="default" size="100%">12</style></number><edition><style face="normal" font="default" size="100%">2016/11/05</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Acne Vulgaris/complications/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Gels</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Pain/etiology</style></keyword><keyword><style face="normal" font="default" size="100%">Phototherapy/*adverse effects/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Quality of Life</style></keyword><keyword><style face="normal" font="default" size="100%">Severity of Illness Index</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0011-9059</style></isbn><accession-num><style face="normal" font="default" size="100%">27575854</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Although a variety of laser/light-based devices have been reported to be effective for the treatment of acne, long-term data on efficacy and safety in the management of moderate and severe inflammatory acne is lacking. The objective of this 12-week clinical trial was to evaluate the efficacy and safety of the KLOX BioPhotonic System, a LED blue light device using specific photo-converter chromophores, in the treatment of moderate to severe acne vulgaris. METHODS: One patient hemiface was randomly selected to receive 6 weeks of treatment (twice weekly) with the LED light and the photo-converter chromophores whereas the contralateral hemiface was not treated with the BioPhotonic System. All patients were provided with a skin cleanser and a non-comedogenic cream with ultraviolet protection to be used on the entire face during the treatment period. Following completion of the 6-week treatment period, the patient was followed for an additional 6 weeks. Efficacy was assessed through changes in acne severity using the Investigator&apos;s Global Assessment (IGA) scale and inflammatory acne lesion counts, both evaluated against baseline at weeks 6 and 12. Safety was assessed through physical exam, vital signs, laboratory evaluations, and physician and patient reporting of adverse events. RESULTS: A reduction of at least two grades in IGA scale severity was demonstrated in 51.7% of patients at week 12. Furthermore, at week 12, subjects with a baseline IGA grade of 3 (moderate) demonstrated a success rate (2 or greater grade drop) of 45.3% whereas patients with a baseline IGA grade of 4 (severe) demonstrated a success rate of 61.1%. Acne inflammatory lesion counts confirmed these results, with a reduction of at least 40% of lesions in 81.6% of treated hemifaces after 12 weeks. Treatment was considered as safe and well tolerated, with no serious adverse event and no patient discontinuation from the study from any adverse event. Patients&apos; quality of life was also improved with a decrease of pain linked to acne after the 6-week treatment period. CONCLUSIONS: The BioPhotonic System comprised of LED blue-light phototherapy and photo-converter chromophores was found to be efficacious and safe, with a sustained clinical response at 12 weeks for the management of moderate to severe facial inflammatory acne.</style></abstract><notes><style face="normal" font="default" size="100%">1365-4632&#xD;Antoniou, Christina&#xD;Dessinioti, Clio&#xD;Sotiriadis, Dimitrios&#xD;Kalokasidis, Konstantinos&#xD;Kontochristopoulos, George&#xD;Petridis, Athanasios&#xD;Rigopoulos, Dimitrios&#xD;Vezina, Denis&#xD;Nikolis, Andreas&#xD;Journal Article&#xD;Multicenter Study&#xD;Randomized Controlled Trial&#xD;England&#xD;Int J Dermatol. 2016 Dec;55(12):1321-1328. doi: 10.1111/ijd.13349. Epub 2016 Aug 30.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/ijd.13349</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">eng</style></language></record><record><database name="SpiderCite demo.enl" path="C:\Users\jclark\OneDrive - Bond University\Training\2023\Workshop 1 SRA overview training\SRA overview demo files\09 SpiderCite\SpiderCite demo.enl">SpiderCite demo.enl</database><source-app name="EndNote" version="20.4">EndNote</source-app><rec-number>3</rec-number><foreign-keys><key app="EN" db-id="e2trw50reds29qedswuva59vp5dpt5f5a9er">3</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ash, C.</style></author><author><style face="normal" font="default" size="100%">Harrison, A.</style></author><author><style face="normal" font="default" size="100%">Drew, S.</style></author><author><style face="normal" font="default" size="100%">Whittall, R.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">The Dezac Group Ltd , Cheltenham , UK.</style></auth-address><titles><title><style face="normal" font="default" size="100%">A randomized controlled study for the treatment of acne vulgaris using high-intensity 414 nm solid state diode arrays</style></title><secondary-title><style face="normal" font="default" size="100%">J Cosmet Laser Ther</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Cosmet Laser Ther</style></full-title></periodical><pages><style face="normal" font="default" size="100%">170-6</style></pages><volume><style face="normal" font="default" size="100%">17</style></volume><number><style face="normal" font="default" size="100%">4</style></number><edition><style face="normal" font="default" size="100%">2015/01/17</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Acne Vulgaris/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Combined Modality Therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Cosmetic Techniques</style></keyword><keyword><style face="normal" font="default" size="100%">Double-Blind Method</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Glycolates/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Keratolytic Agents/administration &amp; dosage/*therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Lactic Acid/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Phototherapy/*instrumentation</style></keyword><keyword><style face="normal" font="default" size="100%">Salicylic Acid/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Severity of Illness Index</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Led</style></keyword><keyword><style face="normal" font="default" size="100%">Rct</style></keyword><keyword><style face="normal" font="default" size="100%">acne vulgaris</style></keyword><keyword><style face="normal" font="default" size="100%">light-emitting diodes</style></keyword><keyword><style face="normal" font="default" size="100%">photorejuvenation</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><isbn><style face="normal" font="default" size="100%">1476-4172</style></isbn><accession-num><style face="normal" font="default" size="100%">25594129</style></accession-num><abstract><style face="normal" font="default" size="100%">The treatment of acne vulgaris poses a challenge to the dermatologist, and the disease causes emotional anxiety for the patient. The treatment of acne vulgaris may be well-suited to home-use applications, where sufferers may be too embarrassed to seek medical treatment. This randomized controlled study is designed to quantify the effectiveness of using a blue light device in a therapy combined with proprietary creams, in the investigation of a self-treatment regimen. A total of 41 adults with mild-to-moderate facial inflammatory acne were recruited. The subjects were randomly assigned to combination blue light therapy (n = 26) or control (n = 15). Photography was used for qualitative assessment of lesion counts, at weeks 1, 2, 4, 8, and 12. All subjects in the treatment cohort achieved a reduction in their inflammatory lesion counts after 12 weeks. The mean inflammatory lesion counts reduced by 50.02% in the treatment cohort, and increased by 2.45% in the control cohort. The reduction in inflammatory lesions was typically observable at week-3, and maximal between weeks 8 and 12. The treatment is free of pain and side-effects. The blue light device offers a valuable alternative to antibiotics and potentially irritating topical treatments. Blue light phototherapy, using a narrow-band LED light source, appears to be a safe and effective additional therapy for mild to moderate acne.</style></abstract><notes><style face="normal" font="default" size="100%">1476-4180&#xD;Ash, Caerwyn&#xD;Harrison, Anna&#xD;Drew, Samantha&#xD;Whittall, Rebecca&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;England&#xD;J Cosmet Laser Ther. 2015;17(4):170-6. doi: 10.3109/14764172.2015.1007064. Epub 2015 Feb 20.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.3109/14764172.2015.1007064</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">eng</style></language></record><record><database name="SpiderCite demo.enl" path="C:\Users\jclark\OneDrive - Bond University\Training\2023\Workshop 1 SRA overview training\SRA overview demo files\09 SpiderCite\SpiderCite demo.enl">SpiderCite demo.enl</database><source-app name="EndNote" version="20.4">EndNote</source-app><rec-number>7</rec-number><foreign-keys><key app="EN" db-id="e2trw50reds29qedswuva59vp5dpt5f5a9er">7</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">de Arruda, L. H.</style></author><author><style face="normal" font="default" size="100%">Kodani, V.</style></author><author><style face="normal" font="default" size="100%">Bastos Filho, A.</style></author><author><style face="normal" font="default" size="100%">Mazzaro, C. B.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Serviço de Dermatologia, Hospital Escola Celso Pierro, Faculdade de Medicina, Pontifícia Universidade Católica de Campinas, Campinas, SP, Brasil. dermato@hmcp.puc-campinas.edu.br</style></auth-address><titles><title><style face="normal" font="default" size="100%">[A prospective, randomized, open and comparative study to evaluate the safety and efficacy of blue light treatment versus a topical benzoyl peroxide 5% formulation in patients with acne grade II and III]</style></title><secondary-title><style face="normal" font="default" size="100%">An Bras Dermatol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">An Bras Dermatol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">463-8</style></pages><volume><style face="normal" font="default" size="100%">84</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2010/01/26</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Acne Vulgaris/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Administration, Topical</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Benzoyl Peroxide/*administration &amp; dosage/adverse effects</style></keyword><keyword><style face="normal" font="default" size="100%">Dermatologic Agents/*administration &amp; dosage/adverse effects</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Phototherapy</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Severity of Illness Index</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep-Oct</style></date></pub-dates></dates><orig-pub><style face="normal" font="default" size="100%">Estudo clínico, prospectivo, aberto, randomizado e comparativo para avaliar a segurança e a eficácia da luz azul versus peróxido de benzoíla 5% no tratamento da acne inflamatória graus II e III.</style></orig-pub><isbn><style face="normal" font="default" size="100%">0365-0596</style></isbn><accession-num><style face="normal" font="default" size="100%">20098847</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Many acne patients improve after exposure to sunlight and there are many reports about the efficacy of blue light phototherapy on acne lesions. OBJECTIVES: The purpose of this study was to evaluate efficacy and safety of blue light treatment versus topical benzoyl peroxide 5% formulation in patients with acne grades II and III. METHODS: Sixty volunteers with facial acne were included and evaluated in 5 visits: the first one for screening, another 3 held on days 7, 14 and 28 of treatment, and the last one after 14 days of the end of treatment. Thirty of them were irradiated with Blue Light (8 times, twice a week) and the other thirty were treated with topical Benzoyl Peroxide 5% formulation, auto-applied twice a day, every day. We assessed the severity of acne by counting the lesions and analyzing the photographs. RESULTS: The improvement achieved by the blue light was the same as the one with benzoyl peroxide, regardless of the type of lesion (p 0.05). Otherwise, the side effects were less frequent in the group treated with blue light. CONCLUSIONS: Blue light irradiation was as effective as benzoyl peroxide in acne treatment grades II and III but there were fewer side effects.</style></abstract><notes><style face="normal" font="default" size="100%">1806-4841&#xD;de Arruda, Lúcia H F&#xD;Kodani, Vanessa&#xD;Bastos Filho, Antonio&#xD;Mazzaro, Carla Bassanezi&#xD;Comparative Study&#xD;English Abstract&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Spain&#xD;An Bras Dermatol. 2009 Sep-Oct;84(5):463-8. doi: 10.1590/s0365-05962009000500003.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1590/s0365-05962009000500003</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">por</style></language></record><record><database name="SpiderCite demo.enl" path="C:\Users\jclark\OneDrive - Bond University\Training\2023\Workshop 1 SRA overview training\SRA overview demo files\09 SpiderCite\SpiderCite demo.enl">SpiderCite demo.enl</database><source-app name="EndNote" version="20.4">EndNote</source-app><rec-number>6</rec-number><foreign-keys><key app="EN" db-id="e2trw50reds29qedswuva59vp5dpt5f5a9er">6</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gold, M. H.</style></author><author><style face="normal" font="default" size="100%">Sensing, W.</style></author><author><style face="normal" font="default" size="100%">Biron, J. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Gold Skin Care Center, Department of Dermatology, School of Nursing, Vanderbilt University School of Medicine, Vanderbilt University, Nashville, TN 37215, USA. goldskin@goldskincare.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">Clinical efficacy of home-use blue-light therapy for mild-to moderate acne</style></title><secondary-title><style face="normal" font="default" size="100%">J Cosmet Laser Ther</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Cosmet Laser Ther</style></full-title></periodical><pages><style face="normal" font="default" size="100%">308-14</style></pages><volume><style face="normal" font="default" size="100%">13</style></volume><number><style face="normal" font="default" size="100%">6</style></number><edition><style face="normal" font="default" size="100%">2011/11/19</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Acne Vulgaris/pathology/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Face</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">*Phototherapy/instrumentation</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Self Administration</style></keyword><keyword><style face="normal" font="default" size="100%">Severity of Illness Index</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style face="normal" font="default" size="100%">Dec</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1476-4172</style></isbn><accession-num><style face="normal" font="default" size="100%">22091799</style></accession-num><abstract><style face="normal" font="default" size="100%">INTRODUCTION: Blue-light light-emitting diode (LED) therapy has become widely used for the treatment of inflammatory acne. In this study we evaluated the efficacy of a home use blue-light LED application in improving lesions and shortening their time to clearance. METHODS: This was an IRB approved randomized self-control study. For each patient (n = 30), 2 similar lesions, one of each side of the face were chosen for treatment with either a blue-light LED hand-held or sham device. Treatments (n = 4) were conducted twice daily in the clinic and lesions were followed-up till resolution. Reduction in blemishes size and erythema and the overall improvement were evaluated by both the physician and the patients. Time to lesion resolution was recorded. RESULTS: There was a significant difference in the response of lesions to the blue-light LED application as opposed to the placebo in terms of reduction in lesion size and lesion erythema as well as the improvement in the overall skin condition (p &lt; 0.025). Signs of improvement were observed as early as post 2 treatments. Time to resolution was significantly shorter for the blue-light LED therapy. CONCLUSION: The results support the effectiveness of using blue-light LED therapy on a daily basis for better improvement and faster resolution of inflammatory acne lesions.</style></abstract><notes><style face="normal" font="default" size="100%">1476-4180&#xD;Gold, Michael H&#xD;Sensing, Whitney&#xD;Biron, Julie A&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;England&#xD;J Cosmet Laser Ther. 2011 Dec;13(6):308-14. doi: 10.3109/14764172.2011.630081.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.3109/14764172.2011.630081</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">eng</style></language></record><record><database name="SpiderCite demo.enl" path="C:\Users\jclark\OneDrive - Bond University\Training\2023\Workshop 1 SRA overview training\SRA overview demo files\09 SpiderCite\SpiderCite demo.enl">SpiderCite demo.enl</database><source-app name="EndNote" version="20.4">EndNote</source-app><rec-number>5</rec-number><foreign-keys><key app="EN" db-id="e2trw50reds29qedswuva59vp5dpt5f5a9er">5</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kwon, H. H.</style></author><author><style face="normal" font="default" size="100%">Lee, J. B.</style></author><author><style face="normal" font="default" size="100%">Yoon, J. Y.</style></author><author><style face="normal" font="default" size="100%">Park, S. Y.</style></author><author><style face="normal" font="default" size="100%">Ryu, H. H.</style></author><author><style face="normal" font="default" size="100%">Park, B. M.</style></author><author><style face="normal" font="default" size="100%">Kim, Y. J.</style></author><author><style face="normal" font="default" size="100%">Suh, D. H.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.</style></auth-address><titles><title><style face="normal" font="default" size="100%">The clinical and histological effect of home-use, combination blue-red LED phototherapy for mild-to-moderate acne vulgaris in Korean patients: a double-blind, randomized controlled trial</style></title><secondary-title><style face="normal" font="default" size="100%">Br J Dermatol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Br J Dermatol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">1088-94</style></pages><volume><style face="normal" font="default" size="100%">168</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2013/01/03</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Acne Vulgaris/pathology/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Asian Continental Ancestry Group</style></keyword><keyword><style face="normal" font="default" size="100%">Double-Blind Method</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Phototherapy/adverse effects/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Republic of Korea</style></keyword><keyword><style face="normal" font="default" size="100%">Sebaceous Glands/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Severity of Illness Index</style></keyword><keyword><style face="normal" font="default" size="100%">Treatment Outcome</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0007-0963</style></isbn><accession-num><style face="normal" font="default" size="100%">23278295</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Blue and red light have been reported to have beneficial effects on acne. However, there has been no double-blind, randomized study of acne treatment for combined blue and red light-emitting diode (LED) devices, and the associated molecular mechanisms have rarely been investigated. OBJECTIVES: To evaluate the efficacy, safety and histological changes of combined blue and red LED phototherapy for acne vulgaris. METHODS: Thirty-five patients with mild-to-moderate acne were randomly assigned to either a home-use irradiation group using an LED device, or a control group using a sham device. The treatment group was instructed to serially irradiate their forehead and cheeks with 420-nm blue light and 660-nm red light for 2.5 min twice daily for 4 weeks. RESULTS: At the final visit at 12 weeks, both inflammatory and noninflammatory acne lesions had decreased significantly, by 77% and 54%, respectively, in the treatment group. No significant difference was observed in the control group. In the treatment group, sebum output reduction, attenuated inflammatory cell infiltrations and a decreased size of the sebaceous gland were found. The immunostaining intensities for interleukin (IL)-8, IL-1α, matrix metalloproteinase-9, toll-like receptor-2, nuclear factor-κB, insulin-like growth factor-1 receptor and sterol response element binding protein (SREBP)-1 were reduced concomitantly. Messenger RNA expression of SREBP-1c was also decreased. No severe adverse reactions were reported. CONCLUSIONS: This LED phototherapy was safe and effective for treating not only inflammatory but also noninflammatory acne lesions, with good compliance. The experimental results correlated well with clinical results, partly elucidating the related molecular mechanisms.</style></abstract><notes><style face="normal" font="default" size="100%">1365-2133&#xD;Kwon, H H&#xD;Lee, J B&#xD;Yoon, J Y&#xD;Park, S Y&#xD;Ryu, H H&#xD;Park, B M&#xD;Kim, Y J&#xD;Suh, D H&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;England&#xD;Br J Dermatol. 2013 May;168(5):1088-94. doi: 10.1111/bjd.12186.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/bjd.12186</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">eng</style></language></record><record><database name="SpiderCite demo.enl" path="C:\Users\jclark\OneDrive - Bond University\Training\2023\Workshop 1 SRA overview training\SRA overview demo files\09 SpiderCite\SpiderCite demo.enl">SpiderCite demo.enl</database><source-app name="EndNote" version="20.4">EndNote</source-app><rec-number>4</rec-number><foreign-keys><key app="EN" db-id="e2trw50reds29qedswuva59vp5dpt5f5a9er">4</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Liu, L. H.</style></author><author><style face="normal" font="default" size="100%">Fan, X.</style></author><author><style face="normal" font="default" size="100%">An, Y. X.</style></author><author><style face="normal" font="default" size="100%">Zhang, J.</style></author><author><style face="normal" font="default" size="100%">Wang, C. M.</style></author><author><style face="normal" font="default" size="100%">Yang, R. Y.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Dermatology, General Hospital of Beijing Military Region of PLA, Beijing, China.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Randomized trial of three phototherapy methods for the treatment of acne vulgaris in Chinese patients</style></title><secondary-title><style face="normal" font="default" size="100%">Photodermatol Photoimmunol Photomed</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Photodermatol Photoimmunol Photomed</style></full-title></periodical><pages><style face="normal" font="default" size="100%">246-53</style></pages><volume><style face="normal" font="default" size="100%">30</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2013/12/10</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Acne Vulgaris/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Phototherapy/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword><keyword><style face="normal" font="default" size="100%">acne vulgaris</style></keyword><keyword><style face="normal" font="default" size="100%">intense pulsed light</style></keyword><keyword><style face="normal" font="default" size="100%">light-emitting diode</style></keyword><keyword><style face="normal" font="default" size="100%">photodynamic therapy</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0905-4383</style></isbn><accession-num><style face="normal" font="default" size="100%">24313686</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND AND AIMS: Acne vulgaris is common in Asian populations. We compared three methods of phototherapy for the treatment of moderate to severe facial acne vulgaris in Chinese patients. METHODS: Patients were randomly assigned to receive photodynamic therapy (PDT), intense pulsed light (IPL) or blue-red light-emitting diode (LED) phototherapy to the right side of the face until the inflammatory lesion count reduced by ≥ 90%. Patients were examined at 1 and 3 months after the final treatment. RESULTS: We enrolled 150 patients (92 males; mean age, 28 years). At 1 month, ≥90% clearance or moderate improvement occurred in 46/50 (92%), 29/50 (58%) and 22/50 (44%) patients in the PDT, IPL and LED groups, respectively (mean number of sessions required, PDT: 3 ± 1.52; IPL: 6 ± 2.15; LED: 9 ± 3.34). Forty-six (92%) patients experienced mild to moderate pain, erythema and edema after PDT, which resolved within 5-7 days. Slight erythema and stinging were reported immediately after IPL and LED, resolving within 2 h. After 3 months, minimal papules and pustules were observed in 4 patients in the PDT group, 7 in the IPL group and 12 in the LED group, but no nodular pustules recurred. CONCLUSIONS: Phototherapy is efficacious for moderate to severe facial acne vulgaris.</style></abstract><notes><style face="normal" font="default" size="100%">1600-0781&#xD;Liu, Li-Hong&#xD;Fan, Xin&#xD;An, Yu-Xi&#xD;Zhang, Jin&#xD;Wang, Cong-Min&#xD;Yang, Rong-Ya&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Photodermatol Photoimmunol Photomed. 2014 Oct;30(5):246-53. doi: 10.1111/phpp.12098. Epub 2014 Jan 6.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/phpp.12098</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">eng</style></language></record><record><database name="SpiderCite demo.enl" path="C:\Users\jclark\OneDrive - Bond University\Training\2023\Workshop 1 SRA overview training\SRA overview demo files\09 SpiderCite\SpiderCite demo.enl">SpiderCite demo.enl</database><source-app name="EndNote" version="20.4">EndNote</source-app><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="e2trw50reds29qedswuva59vp5dpt5f5a9er">1</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nikolis, A.</style></author><author><style face="normal" font="default" size="100%">Fauverghe, S.</style></author><author><style face="normal" font="default" size="100%">Scapagnini, G.</style></author><author><style face="normal" font="default" size="100%">Sotiriadis, D.</style></author><author><style face="normal" font="default" size="100%">Kontochristopoulos, G.</style></author><author><style face="normal" font="default" size="100%">Petridis, A.</style></author><author><style face="normal" font="default" size="100%">Rigopoulos, D.</style></author><author><style face="normal" font="default" size="100%">Dessinioti, C.</style></author><author><style face="normal" font="default" size="100%">Kalokasidis, K.</style></author><author><style face="normal" font="default" size="100%">Antoniou, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Plastic Surgery, University of Montreal, Montreal, Québec, Canada.&#xD;KLOX Technologies Inc., Laval, Québec, Canada.&#xD;Department of Medicine and Health Sciences, School of Medicine, University of Molise, Campobasso, Italy.&#xD;Department of Dermatology, Aristotle University of Thessaloniki Medical School, Papageorgiou General Hospital, Thessaloniki, Greece.&#xD;2nd Department of Dermatology, Andreas Syggros Hospital, Athens, Greece.&#xD;3rd Department of Dermatology, Andreas Syggros Hospital, Athens, Greece.&#xD;Attikon University General Hospital of Athens, University of Athens, Athens, Greece.&#xD;1st Department of Dermatology, Andreas Syggros Hospital, University of Athens, Athens, Greece.</style></auth-address><titles><title><style face="normal" font="default" size="100%">An extension of a multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Dermatol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Int J Dermatol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">94-103</style></pages><volume><style face="normal" font="default" size="100%">57</style></volume><number><style face="normal" font="default" size="100%">1</style></number><edition><style face="normal" font="default" size="100%">2017/11/21</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Acne Vulgaris/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Color</style></keyword><keyword><style face="normal" font="default" size="100%">Facial Dermatoses/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Gels</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Patient Compliance</style></keyword><keyword><style face="normal" font="default" size="100%">Phototherapy/adverse effects/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Severity of Illness Index</style></keyword><keyword><style face="normal" font="default" size="100%">Treatment Outcome</style></keyword><keyword><style face="normal" font="default" size="100%">Young Adult</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jan</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0011-9059</style></isbn><accession-num><style face="normal" font="default" size="100%">29152718</style></accession-num><abstract><style face="normal" font="default" size="100%">A variety of laser/light-based devices have been reported to be effective for the treatment of acne, yet no long-term data on efficacy and safety have been published. A first 12-week clinical trial (&quot;Main trial&quot;) recently demonstrated that the KLOX BioPhotonic System, an LED blue light device using photo-converter chromophores, can significantly improve moderate and severe facial acne vulgaris with an excellent safety profile. This Extension trial followed the Main trial, using the same BioPhotonic System, with the same dose and instructions for use, on patients having already completed treatment in the Main trial. Main objectives of this open-label long-term extension 12-week study were to evaluate the efficacy of the KLOX BioPhotonic System on the untreated hemiface during the Main trial, as well as the duration of response on the hemiface treated during the first 12-week Main trial. Despite their young age (mean age: 21.6 years) and their 12-week participation in the Main trial, 49 (54.4%) of the total number of patients who participated in the Main trial enrolled in this additional 12-week Extension trial. Baseline grading of acne was performed with the Investigator&apos;s Global Assessment (IGA) scale. For each patient, the hemiface randomly selected as a control during the Main trial received 6 weeks of treatment (twice weekly) and was then followed up for an additional 6 weeks. The first hemiface treated in the Main trial was consequently observed throughout the Extension trial, allowing for a further 12-week assessment of outcomes (total 24 weeks). In light of an additional 12 weeks of treatment on the contralateral face, the patient compliance rate was excellent, with 91.9% of the total number of patients receiving at least 80% of the treatments. Patients with a baseline IGA grade of 2 (mild) on the treated hemiface demonstrated a success rate of 58.3 and 66.7% at weeks 6 and 12, respectively. At these same time points, subjects with a baseline IGA grade of 3 (moderate) demonstrated a success rate of 81.8 and 90.0%. Patients with a baseline IGA grade of 4 (severe) demonstrated a success rate of 100% at both week 6 and week 12. When evaluating the originally treated hemifaces from the Main trial, the rate of return to baseline at 24 weeks was calculated to be 15.5%. This latter outcome confirmed the long duration of effect following treatment. The patient safety profile was also excellent, with very few related adverse events. The BioPhotonic System, which is comprised of LED blue light phototherapy and photo-converter chromophores, provides long-term efficacy and safety in the treatment of acne vulgaris, with a rate of compliance above what is generally observed in a young population of patients suffering from acne vulgaris, especially in light of sequential enrollment in a study treating one hemiface.</style></abstract><notes><style face="normal" font="default" size="100%">1365-4632&#xD;Nikolis, Andreas&#xD;Fauverghe, Stéphane&#xD;Scapagnini, Giovanni&#xD;Sotiriadis, Dimitrios&#xD;Kontochristopoulos, George&#xD;Petridis, Athanasios&#xD;Rigopoulos, Dimitrios&#xD;Dessinioti, Clio&#xD;Kalokasidis, Konstantinos&#xD;Antoniou, Christina&#xD;Journal Article&#xD;Multicenter Study&#xD;Randomized Controlled Trial&#xD;England&#xD;Int J Dermatol. 2018 Jan;57(1):94-103. doi: 10.1111/ijd.13814. Epub 2017 Nov 20.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/ijd.13814</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">eng</style></language></record><record><database name="SpiderCite demo.enl" path="C:\Users\jclark\OneDrive - Bond University\Training\2023\Workshop 1 SRA overview training\SRA overview demo files\09 SpiderCite\SpiderCite demo.enl">SpiderCite demo.enl</database><source-app name="EndNote" version="20.4">EndNote</source-app><rec-number>10</rec-number><foreign-keys><key app="EN" db-id="e2trw50reds29qedswuva59vp5dpt5f5a9er">10</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Papageorgiou, P.</style></author><author><style face="normal" font="default" size="100%">Katsambas, A.</style></author><author><style face="normal" font="default" size="100%">Chu, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Unit of Dermatology, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, DuCane Road, London W12 0NN, U.K.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris</style></title><secondary-title><style face="normal" font="default" size="100%">Br J Dermatol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Br J Dermatol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">973-8</style></pages><volume><style face="normal" font="default" size="100%">142</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2000/05/16</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Acne Vulgaris/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Benzoyl Peroxide/adverse effects/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Dermatologic Agents/adverse effects/therapeutic use</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Phototherapy/adverse effects/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Single-Blind Method</style></keyword><keyword><style face="normal" font="default" size="100%">Treatment Outcome</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2000</style></year><pub-dates><date><style face="normal" font="default" size="100%">May</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0007-0963 (Print)&#xD;0007-0963</style></isbn><accession-num><style face="normal" font="default" size="100%">10809858</style></accession-num><abstract><style face="normal" font="default" size="100%">In this study we have evaluated the use of blue light (peak at 415 nm) and a mixed blue and red light (peaks at 415 and 660 nm) in the treatment of acne vulgaris. One hundred and seven patients with mild to moderate acne vulgaris were randomized into four treatment groups: blue light, mixed blue and red light, cool white light and 5% benzoyl peroxide cream. Subjects in the phototherapy groups used portable light sources and irradiation was carried out daily for 15 min. Comparative assessment between the three light sources was made in an observer-blinded fashion, but this could not be achieved for the use of benzoyl peroxide. Assessments were performed every 4 weeks. After 12 weeks of active treatment a mean improvement of 76% (95% confidence interval 66-87) in inflammatory lesions was achieved by the combined blue-red light phototherapy; this was significantly superior to that achieved by blue light (at weeks 4 and 8 but not week 12), benzoyl peroxide (at weeks 8 and 12) or white light (at each assessment). The final mean improvement in comedones by using blue-red light was 58% (95% confidence interval 45-71), again better than that achieved by the other active treatments used, although the differences did not reach significant levels. We have found that phototherapy with mixed blue-red light, probably by combining antibacterial and anti-inflammatory action, is an effective means of treating acne vulgaris of mild to moderate severity, with no significant short-term adverse effects.</style></abstract><notes><style face="normal" font="default" size="100%">Papageorgiou, P&#xD;Katsambas, A&#xD;Chu, A&#xD;Clinical Trial&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;England&#xD;Br J Dermatol. 2000 May;142(5):973-8. doi: 10.1046/j.1365-2133.2000.03481.x.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1046/j.1365-2133.2000.03481.x</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">eng</style></language></record><record><database name="SpiderCite demo.enl" path="C:\Users\jclark\OneDrive - Bond University\Training\2023\Workshop 1 SRA overview training\SRA overview demo files\09 SpiderCite\SpiderCite demo.enl">SpiderCite demo.enl</database><source-app name="EndNote" version="20.4">EndNote</source-app><rec-number>8</rec-number><foreign-keys><key app="EN" db-id="e2trw50reds29qedswuva59vp5dpt5f5a9er">8</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sami, N. A.</style></author><author><style face="normal" font="default" size="100%">Attia, A. T.</style></author><author><style face="normal" font="default" size="100%">Badawi, A. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Dermatology Unit, National Institute of Laser Enhanced Sciences, Cairo University, Egypt. nevien_a_sami@hotmail.com</style></auth-address><titles><title><style face="normal" font="default" size="100%">Phototherapy in the treatment of acne vulgaris</style></title><secondary-title><style face="normal" font="default" size="100%">J Drugs Dermatol</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Drugs Dermatol</style></full-title></periodical><pages><style face="normal" font="default" size="100%">627-32</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><number><style face="normal" font="default" size="100%">7</style></number><edition><style face="normal" font="default" size="100%">2008/07/31</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Acne Vulgaris/drug therapy/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Laser Therapy/adverse effects/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Photochemotherapy/adverse effects/methods</style></keyword><keyword><style face="normal" font="default" size="100%">Phototherapy/adverse effects/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Treatment Outcome</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1545-9616 (Print)&#xD;1545-9616</style></isbn><accession-num><style face="normal" font="default" size="100%">18664153</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Achieving an effective management of acne vulgaris with minimal complications remains a difficult challenge for physicians. Moreover, the rise in antibiotic-resistant strains reduce the future usefulness of current mainstay therapies, and accordingly, the need for alternative therapies is mandatory. Phototherapy has been shown to be an effective treatment for acne, and there has been a renewed interest in photodynamic therapy as a treatment modality for this condition. OBJECTIVES: To evaluate the effectiveness of pulsed dye laser (PDL), intense pulsed light (IPL) and light-emitting diode (LED) phototherapy for the treatment of moderate to severe acne vulgaris. METHODS: Forty-five patients with moderate to severe acne were randomly divided into 3 equal groups. Group 1 was treated with a PDL, group 2 was treated with IPL, and group 3 was treated with a blue-red combination LED. Treatment was continued until a &gt; or = 90% clearance of patient lesions was achieved. Clinical assessments were conducted before starting treatment, at 1 month as a midpoint evaluation, and after the final treatment session. RESULTS: Patients treated with the PDL reached a &gt; or = 90% clearance of their inflammatory lesions after a mean of 4.1 +/- 1.39 sessions, while patients treated with IPL required a mean of 6 +/- 2.05 sessions. Patients treated with the LED required a mean of 10 +/- 3.34 sessions. At the mid-point evaluation, the percent reduction in acne lesions treated with the PDL was 90% or more, in cases of IPL and the LED, the percent reductions were 41.7% and 35.3%, respectively. Laser and light phototherapy sessions were well tolerated with minimal adverse events experienced as being mild and usually self-limiting. CONCLUSIONS: The encouraging results of the present study contributes evidence of phototherapy as useful therapeutic option for treatment of moderate to severe acne, and validates further studies to evaluate treatments with a larger number of patients and for a longer period of follow-up.</style></abstract><notes><style face="normal" font="default" size="100%">Sami, Nevien A&#xD;Attia, Abeer T&#xD;Badawi, Ashraf M&#xD;Comparative Study&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;United States&#xD;J Drugs Dermatol. 2008 Jul;7(7):627-32.</style></notes><urls></urls><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">eng</style></language></record><record><database name="SpiderCite demo.enl" path="C:\Users\jclark\OneDrive - Bond University\Training\2023\Workshop 1 SRA overview training\SRA overview demo files\09 SpiderCite\SpiderCite demo.enl">SpiderCite demo.enl</database><source-app name="EndNote" version="20.4">EndNote</source-app><rec-number>9</rec-number><foreign-keys><key app="EN" db-id="e2trw50reds29qedswuva59vp5dpt5f5a9er">9</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tzung, T. Y.</style></author><author><style face="normal" font="default" size="100%">Wu, K. H.</style></author><author><style face="normal" font="default" size="100%">Huang, M. L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Dermatology, Veterans General Hospital Kaohsiung, 386 Ta-Chung 1st Road, Kaohsiung 813, Taiwan. tytzung@isca.vghks.gov.tw</style></auth-address><titles><title><style face="normal" font="default" size="100%">Blue light phototherapy in the treatment of acne</style></title><secondary-title><style face="normal" font="default" size="100%">Photodermatol Photoimmunol Photomed</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Photodermatol Photoimmunol Photomed</style></full-title></periodical><pages><style face="normal" font="default" size="100%">266-9</style></pages><volume><style face="normal" font="default" size="100%">20</style></volume><number><style face="normal" font="default" size="100%">5</style></number><edition><style face="normal" font="default" size="100%">2004/09/24</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Acne Vulgaris/classification/pathology/*therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Cicatrix/classification/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Cicatrix, Hypertrophic/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Facial Dermatoses/classification/pathology/therapy</style></keyword><keyword><style face="normal" font="default" size="100%">Female</style></keyword><keyword><style face="normal" font="default" size="100%">Fluorescence</style></keyword><keyword><style face="normal" font="default" size="100%">Follow-Up Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Hair Follicle/metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Male</style></keyword><keyword><style face="normal" font="default" size="100%">Phototherapy/*methods</style></keyword><keyword><style face="normal" font="default" size="100%">Porphyrins/analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Skin/pathology</style></keyword><keyword><style face="normal" font="default" size="100%">Treatment Outcome</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2004</style></year><pub-dates><date><style face="normal" font="default" size="100%">Oct</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">0905-4383 (Print)&#xD;0905-4383</style></isbn><accession-num><style face="normal" font="default" size="100%">15379878</style></accession-num><abstract><style face="normal" font="default" size="100%">BACKGROUND: Blue light irradiation is known to be effective against acne. However, the profile of a good candidate is still unclear. METHODS: Thirty-one Taiwanese with symmetrical facial acne were irradiated with blue light on one side of the face selected randomly twice weekly for 4 consecutive weeks. The other half of the face was left untreated as control. Parameters, including scar type, pore size, and facial follicular porphyrin fluorescence intensity, were documented. The severity of acne was assessed before the treatment, after two, four, and eight sessions of treatment, and 1 month after the treatment was completed. RESULTS: Compared with the non-irradiation side, eight sessions of blue light irradiation were effective in acne treatment (P&lt;0.001). Gender (P=0.471), scar type (P-values of pitted, atrophic, and hypertrophic type were 0.688, 0.572, and 0.802, respectively), pore size (P=0.755), and pretreatment fluorescence intensity (P=0.656) could not be used as predictive factors of therapeutic effectiveness. Compared with pretreatment, nodulocystic lesions tended to worsen despite treatment. In addition, the therapeutic effectiveness was not related to the fluorescence intensity change (P=0.812). CONCLUSIONS: Blue light irradiation is effective in acne treatment. Patients without nodulocystic lesions are better candidates for blue light irradiation.</style></abstract><notes><style face="normal" font="default" size="100%">Tzung, Tien-Yi&#xD;Wu, Kuan-Hsing&#xD;Huang, Mei-Lun&#xD;Clinical Trial&#xD;Comparative Study&#xD;Journal Article&#xD;Randomized Controlled Trial&#xD;England&#xD;Photodermatol Photoimmunol Photomed. 2004 Oct;20(5):266-9. doi: 10.1111/j.1600-0781.2004.00109.x.</style></notes><urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/j.1600-0781.2004.00109.x</style></electronic-resource-num><remote-database-provider><style face="normal" font="default" size="100%">NLM</style></remote-database-provider><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>